Feed aggregator

ASCO24: Nimbus Plots Path for Next-Gen IO Therapies with Strong Early HPK1 Blocker Data

Biospace news - Fri, 05/24/2024 - 02:00
ASCO24: Nimbus Plots Path for Next-Gen IO Therapies with Strong Early HPK1 Blocker Data 5/24/2024

Zealand Touts Phase I Results for GLP-1, GLP-2 Candidate Despite Modest Weight Loss

Biospace news - Fri, 05/24/2024 - 02:00
Zealand Touts Phase I Results for GLP-1, GLP-2 Candidate Despite Modest Weight Loss 5/24/2024

Takeda Joins Hot Molecular Glue Market With $1.2B Deal

Biospace news - Thu, 05/23/2024 - 02:00
Takeda Joins Hot Molecular Glue Market With $1.2B Deal 5/23/2024

Pfizer Targets Another $1.5B in Cost Cuts By End of 2027

Biospace news - Thu, 05/23/2024 - 02:00
Pfizer Targets Another $1.5B in Cost Cuts By End of 2027 5/23/2024

Tango Stops Early Cancer Trial Over Liver Toxicity, Drops Out of Race Against Roche

Biospace news - Thu, 05/23/2024 - 02:00
Tango Stops Early Cancer Trial Over Liver Toxicity, Drops Out of Race Against Roche 5/23/2024

Orna Buys Competing RNA Biotech ReNAgade After Series A Financing

Biospace news - Thu, 05/23/2024 - 02:00
Orna Buys Competing RNA Biotech ReNAgade After Series A Financing 5/23/2024

FDA Flags Hypoglycemia Risk for Novo’s Once-Weekly Insulin Ahead of Adcomm

Biospace news - Thu, 05/23/2024 - 02:00
FDA Flags Hypoglycemia Risk for Novo’s Once-Weekly Insulin Ahead of Adcomm 5/23/2024

Appeals Court Sides With Drugmakers in 340B Case, Allows Limits on Discounts Under Program

Biospace news - Thu, 05/23/2024 - 02:00
Appeals Court Sides With Drugmakers in 340B Case, Allows Limits on Discounts Under Program 5/23/2024

Moderna Among Companies Partnering With OpenAI to Boost AI Efforts

Biospace news - Thu, 05/23/2024 - 02:00
Moderna Among Companies Partnering With OpenAI to Boost AI Efforts 5/23/2024

BioSpace x DIA: Navigating the Emergence of CGT Combination Products

Biospace news - Thu, 05/23/2024 - 02:00
BioSpace x DIA: Navigating the Emergence of CGT Combination Products 5/23/2024

Do You Need to Love Your Job to Be Happy at Your Job?

Biospace news - Thu, 05/23/2024 - 02:00
Do You Need to Love Your Job to Be Happy at Your Job? 5/23/2024

AstraZeneca Sets $80B Revenue Target, Goal of 20 New Drugs by 2030

Biospace news - Tue, 05/21/2024 - 02:00
AstraZeneca Sets $80B Revenue Target, Goal of 20 New Drugs by 2030 5/21/2024

FDA Greenlights Two Interchangeable Biosimilars to Regeneron’s Eylea

Biospace news - Tue, 05/21/2024 - 02:00
FDA Greenlights Two Interchangeable Biosimilars to Regeneron’s Eylea 5/21/2024

Lilly Inks Potential $1.1B Radiopharma Deal with Aktis Oncology

Biospace news - Tue, 05/21/2024 - 02:00
Lilly Inks Potential $1.1B Radiopharma Deal with Aktis Oncology 5/21/2024

Sanofi, Regeneron Post Strong Phase III COPD Data for Dupixent as FDA Decision Looms

Biospace news - Tue, 05/21/2024 - 02:00
Sanofi, Regeneron Post Strong Phase III COPD Data for Dupixent as FDA Decision Looms 5/21/2024

GSK’s Long-Acting Asthma Drug Hits Primary Endpoint in Phase III Trials

Biospace news - Tue, 05/21/2024 - 02:00
GSK’s Long-Acting Asthma Drug Hits Primary Endpoint in Phase III Trials 5/21/2024

AltruBio Raises $225M in Series B to Advance Ulcerative Colitis Candidate

Biospace news - Tue, 05/21/2024 - 02:00
AltruBio Raises $225M in Series B to Advance Ulcerative Colitis Candidate 5/21/2024

BIO Axes 30 Staff in Realignment as Congress Advances BIOSECURE Act

Biospace news - Tue, 05/21/2024 - 02:00
BIO Axes 30 Staff in Realignment as Congress Advances BIOSECURE Act 5/21/2024

Amgen Wins FDA Approval for Difficult-to-Treat Lung Cancer

Biospace news - Fri, 05/17/2024 - 02:00
Amgen Wins FDA Approval for Difficult-to-Treat Lung Cancer 5/17/2024

GSK to Sell Remaining Stake in Haleon, Looks to Raise $1.52B

Biospace news - Fri, 05/17/2024 - 02:00
GSK to Sell Remaining Stake in Haleon, Looks to Raise $1.52B 5/17/2024